Measles epidemic from 1951 to 2012 and vaccine effectiveness in Guangzhou, southern China
- PMID: 24513504
- PMCID: PMC4896522
- DOI: 10.4161/hv.27895
Measles epidemic from 1951 to 2012 and vaccine effectiveness in Guangzhou, southern China
Abstract
Background: Since the National Expanded Program on Immunization was implemented in China, considerable progress has been made in reducing the incidence of measles. However, the incidence of measles increased again in 2004. Few post-marketing studies on measles vaccine effectiveness were reported in China. In this study, we aimed to describe the measles epidemic and to evaluate the effectiveness of the measles vaccine in Guangzhou, southern China.
Methods: Based on the surveillance data for measles, we investigated the epidemiology during different periods between 1951 and 2012. We analyzed the clinical characteristics of laboratory-confirmed cases of measles between 2009 and 2012 and conducted a case-control study using test-negative cases as controls. We determined the protective effect of measles vaccine.
Results: The highest annual incidence in Guangzhou was 2187.15/100,000 in 1964, and the lowest was 0.32/100,000 in 2011. The average incidence of measles from 1951 to 2012 was 306.27/100,000. There was a significant tendency of decline in recent years. From 2009 to 2012, there are 700 laboratory-confirmed cases were reported with an average onset age of 2.5 (median) years. The non-vaccinated target population (age<8 months and ≥ 15 years) accounted for 56.7% of the cases. The transient (non-resident) population accounted for 51.3% of the cases. Fewer cases were observed in the population targeted for measles vaccine (aged 8 months to 14 years). The effectiveness of a single dose of the measles vaccine was 89.1% (95% confidence interval (CI), 44.5-97.9), and the effectiveness of ≥ 2 doses of the measles vaccine was 97.8% (95% CI, 88.3-99.6) in children aged 8 months to 14 years old.
Conclusions: There is a significant overall decline in the incidence of measles (including clinical and laboratory confirmed cases) in the measles vaccine targeted population in Guangzhou. Two doses of measles vaccine are more effective than one dose in preventing measles in China. In order to accelerate the elimination of measles, vaccination should also be given to the transient and the non-vaccine targeted population.
Keywords: China; case-control studies; measles elimination; measles epidemic; vaccine effectiveness.
Figures
Similar articles
-
Classification of measles cases from 2014 to 2018: Implications for progress towards measles elimination in China.Vaccine. 2020 May 8;38(22):3832-3838. doi: 10.1016/j.vaccine.2020.03.049. Epub 2020 Apr 10. Vaccine. 2020. PMID: 32280040
-
Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.Am J Epidemiol. 1999 Dec 1;150(11):1250-7. doi: 10.1093/oxfordjournals.aje.a009952. Am J Epidemiol. 1999. PMID: 10588086
-
Risk factors for measles in children aged 8 months-14 years in China after nationwide measles campaign: A multi-site case-control study, 2012-2013.Vaccine. 2016 Dec 12;34(51):6545-6552. doi: 10.1016/j.vaccine.2016.02.005. Epub 2016 Feb 11. Vaccine. 2016. PMID: 26876440 Free PMC article.
-
Measles vaccine effectiveness in African children: a systematic review and meta-analysis.BMC Infect Dis. 2024 Nov 21;24(1):1330. doi: 10.1186/s12879-024-10239-w. BMC Infect Dis. 2024. PMID: 39574018 Free PMC article.
-
The Epidemiology and Diagnosis of Measles—Special Aspects Relating to Low Incidence.Dtsch Arztebl Int. 2024 Dec 27;121(26):875-881. doi: 10.3238/arztebl.m2024.0211. Dtsch Arztebl Int. 2024. PMID: 39600137 Free PMC article. Review.
Cited by
-
Characteristics of measles epidemics in China (1951-2004) and implications for elimination: A case study of three key locations.PLoS Comput Biol. 2019 Feb 4;15(2):e1006806. doi: 10.1371/journal.pcbi.1006806. eCollection 2019 Feb. PLoS Comput Biol. 2019. PMID: 30716080 Free PMC article.
-
Waning of maternal antibody against measles virus in Shufu, China.Hum Vaccin Immunother. 2022 Nov 30;18(6):2045854. doi: 10.1080/21645515.2022.2045854. Epub 2022 Nov 18. Hum Vaccin Immunother. 2022. PMID: 36399713 Free PMC article.
-
The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.Epidemiology. 2020 Jan;31(1):43-64. doi: 10.1097/EDE.0000000000001116. Epidemiology. 2020. PMID: 31609860 Free PMC article.
-
Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development.Drugs R D. 2016 Dec;16(4):327-338. doi: 10.1007/s40268-016-0144-x. Drugs R D. 2016. PMID: 27696306 Free PMC article.
-
A report of outbreaks of measles on the southern coast of Iran from 2009 to 2015.Electron Physician. 2017 Mar 25;9(3):3997-4002. doi: 10.19082/3997. eCollection 2017 Mar. Electron Physician. 2017. PMID: 28461876 Free PMC article.
References
-
- Atkinson WL. . Epidemiology and prevention of measles. Dermatol Clin 1995; 13:553 - 9; PMID: 7554503 - PubMed
-
- Campbell H, Andrews N, Brown KE, Miller E. . Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol 2007; 36:1334 - 48; http://dx.doi.org/10.1093/ije/dym207; PMID: 18037676 - DOI - PubMed
-
- Duke T, Mgone CS. . Measles: not just another viral exanthem. Lancet 2003; 361:763 - 73; http://dx.doi.org/10.1016/S0140-6736(03)12661-X; PMID: 12620751 - DOI - PubMed
-
- Perry RT, Halsey NA. . The clinical significance of measles: a review. J Infect Dis 2004; 189:Suppl 1 S4 - 16; http://dx.doi.org/10.1086/377712; PMID: 15106083 - DOI - PubMed
-
- Centers for Disease Control and Prevention (CDC). . Measles--United States, 1999. MMWR Morb Mortal Wkly Rep 2000; 49:557 - 60; PMID: 10921493 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical